GPD1L and colorectal carcinoma: Our investigation systematically evaluates: (i) the differential expression patterns of GPD1L in CRC versus normal mucosa, (ii) its clinicopathological correlations, (iii) functional consequences of GPD1L reconstitution on malignant phenotypes in vitro, and (iv) the molecular mechanism of GPD1L influencing CRC cells.